Correlation Between Northwest Biotherapeutics and Climb Bio

Can any of the company-specific risk be diversified away by investing in both Northwest Biotherapeutics and Climb Bio at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Northwest Biotherapeutics and Climb Bio into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Northwest Biotherapeutics and Climb Bio, you can compare the effects of market volatilities on Northwest Biotherapeutics and Climb Bio and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Northwest Biotherapeutics with a short position of Climb Bio. Check out your portfolio center. Please also check ongoing floating volatility patterns of Northwest Biotherapeutics and Climb Bio.

Diversification Opportunities for Northwest Biotherapeutics and Climb Bio

0.73

Correlation Coefficient

Northwest Biotherapeutics  Climb Bio

Poor diversification

The 3 months correlation between Northwest and Climb is 0.73. Overlapping area represents the amount of risk that can be diversified away by holding Northwest Biotherapeutics and Climb Bio in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Climb Bio and Northwest Biotherapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Northwest Biotherapeutics are associated (or correlated) with Climb Bio. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Climb Bio has no effect on the direction of Northwest Biotherapeutics i.e., Northwest Biotherapeutics and Climb Bio go up and down completely randomly.

Pair Corralation between Northwest Biotherapeutics and Climb Bio

Given the investment horizon of 90 days Northwest Biotherapeutics is expected to generate 1.0 times more return on investment than Climb Bio. However, Northwest Biotherapeutics is 1.0 times more volatile than Climb Bio. It trades about -0.05 of its potential returns per unit of risk. Climb Bio is currently generating about -0.4 per unit of risk. If you would invest  28.00  in Northwest Biotherapeutics on September 22, 2024 and sell it today you would lose (2.00) from holding Northwest Biotherapeutics or give up 7.14% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Significant
Accuracy	100.0%
Values	Daily Returns

Northwest Biotherapeutics  vs.  Climb Bio

Northwest Biotherapeutics

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Northwest Biotherapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unsteady performance in the last few months, the Stock's fundamental drivers remain very healthy which may send shares a bit higher in January 2025. The recent disarray may also be a sign of long period up-swing for the firm investors.

Climb Bio

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Climb Bio has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's basic indicators remain very healthy which may send shares a bit higher in January 2025. The recent disarray may also be a sign of long period up-swing for the firm investors.

Pair Trading with Northwest Biotherapeutics and Climb Bio

The main advantage of trading using opposite Northwest Biotherapeutics and Climb Bio positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Northwest Biotherapeutics position performs unexpectedly, Climb Bio can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Climb Bio will offset losses from the drop in Climb Bio's long position.

The idea behind Northwest Biotherapeutics and Climb Bio pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Investing Opportunities module to build portfolios using our predefined set of ideas and optimize them against your investing preferences.